Data as of 12:14pm ET
| -0.205 / -6.27%|
The 1 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +30.51% increase from the last price of 3.07.
The current consensus among 1 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.